In our integrative bioinformatics analysis and pathway enrichment analysis, FOS stands out as one of the most significantly upregulated core-enriched genes in B-ALL following ZNF217 depletion, but FOS is unlikely to be the sole critical downstream target of ZNF217 in B-ALL. The gene discussed is FOS; the disease is precursor B-cell acute lymphoblastic leukemia.